| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Metagenomi Therapeutics, Inc. (MGX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. MGX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.51M | $3.09M | - | |
| Other | 377.5K | $464.4K | -3,737 | |
| CFO | 208.5K | $256.4K | -2,884 | |
| Other | 126.5K | $155.6K | -558 | |
| Dir | 21.0K | $25.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | Wein Matthew66 | See Remarks | Sell | 199 | $1.81 | $360.19 | -1.0% | -6.3% | - | |
| Jun 6, 2025 | Wein Matthew66 | See Remarks | Sell | 199 | $1.75 | $348.25 | -1.2% | +2.9% | -26.0% | |
| Jun 6, 2025 | Noonberg Sarah B. | Chief Medical Officer | Sell | 5,239 | $1.75 | $9,168.25 | -4.6% | +2.9% | -26.0% | |
| Jun 6, 2025 | Wapnick Pamela69 | Chief Financial Officer | Sell | 1,576 | $1.75 | $2,758.00 | -2.1% | +2.9% | -26.0% | |
| Jun 6, 2025 | Thomas Brian C.64 | Chief Executive Officer | Sell | 10,785 | $1.75 | $18,873.75 | -0.4% | +2.9% | -26.0% | |
| Jun 6, 2025 | Irish Jian64 | See Remarks | Sell | 6,390 | $1.75 | $11,182.50 | -2.0% | +2.9% | -26.0% | |
| Mar 5, 2025 | Wein Matthew66 | See Remarks | Sell | 930 | $1.87 | $1,743.56 | -8.9% | -9.2% | -17.4% | |
| Mar 5, 2025 | Wapnick Pamela69 | Chief Financial Officer | Sell | 1,808 | $1.87 | $3,389.64 | -2.9% | -9.2% | -17.4% | |
| Dec 5, 2024 | Wapnick Pamela69 | Chief Financial Officer | Sell | 1,559 | $1.86 | $2,899.74 | -2.5% | +5.4% | -3.8% | |
| Sep 5, 2024 | Wapnick Pamela69 | Chief Financial Officer | Sell | 6,265 | $2.88 | $18,043.20 | -9.0% | -35.9% | -34.1% |